Evaluation of apoptosis-induction by newly synthesized phthalazine derivatives in breast cancer cell lines.

作者: Hassan Y Aboul-Enein , Adnan A Bekhit , Manogaran P Subramanian , Jamal M Arif , Fahad M Al-Khodairy

DOI:

关键词:

摘要: Newly synthesized phthalazine derivatives including copper and platinum complexes were evaluated for cytotoxicity in human breast cancer cell lines. The cells incubated with the compounds (100 µM) 72 h cytotoxicity, apoptosis DNA content measured by flow cytometery. Our results suggest that parent (H12), (C1-2)- (P1-2)-derivatized relatively more active inducing killing both lines, MDA-MB-231 being sensitive. Other showed weak or no response towards these parameters except H-5 causing 40% cells. Addition of structures generally reduced apoptotic potential. Possible roles structure activity relationships are discussed.

参考文章(24)
Rakesh K. Srivastava, Aparna R. Srivastava, Stanley J. Korsmeyer, Maria Nesterova, Yoon S. Cho-Chung, Dan L. Longo, Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Molecular and Cellular Biology. ,vol. 18, pp. 3509- 3517 ,(1998) , 10.1128/MCB.18.6.3509
Jeanette M Wood, G Bold, Elizabeth Buchdunger, R Cozens, Stefano Ferrari, Jörg Frei, F Hofmann, Jürgen Mestan, H Mett, Terence O’Reilly, Elke Persohn, Johannes Rösel, Christian Schnell, David Stover, A Theuer, Harry Towbin, Fritz Wenger, K Woods-Cook, A Menrad, Gerhard Siemeister, M Schirner, Karl-Heinz Thierauch, Martin R Schneider, J Drevs, G Martiny-Baron, F Totzke, Dieter Marmé, PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration Cancer Research. ,vol. 60, pp. 2178- 2189 ,(2000)
I. Kostova, Lanthanides as anticancer agents. Current Medicinal Chemistry - Anti-cancer Agents. ,vol. 5, pp. 591- 602 ,(2005) , 10.2174/156801105774574694
Dong Wang, Stephen J. Lippard, Cellular processing of platinum anticancer drugs. Nature Reviews Drug Discovery. ,vol. 4, pp. 307- 320 ,(2005) , 10.1038/NRD1691
Michael J. Genin, Carolyn Biles, Barb J. Keiser, Susan M. Poppe, Steven M. Swaney, W. Gary Tarpley, Yoshihiko Yagi, Donna L. Romero, Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: lead identification and SAR of 3- and 4-substituted derivatives. Journal of Medicinal Chemistry. ,vol. 43, pp. 1034- 1040 ,(2000) , 10.1021/JM990383F
Charles R. Petrie, Ganapathi R. Revankar, N. Kent Dalley, Rose D. George, Patricia A. McKernan, Robert L. Hamill, Roland K. Robins, Synthesis and biological activity of certain nucleoside and nucleotide derivatives of pyrazofurin. Journal of Medicinal Chemistry. ,vol. 29, pp. 268- 278 ,(1986) , 10.1021/JM00152A016
Michael J. Genin, Debra A. Allwine, David J. Anderson, Michael R. Barbachyn, D. Edward Emmert, Stuart A. Garmon, David R. Graber, Kevin C. Grega, Jackson B. Hester, Douglas K. Hutchinson, Joel Morris, Robert J. Reischer, Charles W. Ford, Gary E. Zurenko, Judith C. Hamel, Ronda D. Schaadt, Douglas Stapert, Betty H. Yagi, Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. Journal of Medicinal Chemistry. ,vol. 43, pp. 953- 970 ,(2000) , 10.1021/JM990373E
Nial Wheate, J. Collins, Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy Current Medicinal Chemistry-Anti-Cancer Agents. ,vol. 5, pp. 267- 279 ,(2005) , 10.2174/1568011053765994
N.K. Singh, Nagendra Singh, G.C. Prasad, A. Sodhi, Anju Shrivastava, Antitumor activity studies of newly synthesized N-salicyloyl-N′-(p-hydroxybenzthioyl)hydrazine and its Copper(II) complex both in vivo and in vitro Bioorganic & Medicinal Chemistry. ,vol. 5, pp. 245- 251 ,(1997) , 10.1016/S0968-0896(96)00243-X